Volume | 2,411,711 |
|
|||||
News | - | ||||||
Day High | 0.784 | Low High |
|||||
Day Low | 0.72065 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Gritstone bio Inc | GRTS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.73 | 0.72065 | 0.784 | 0.7386 | 0.7455 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,517 | 2,411,711 | $ 0.7472924 | $ 1,802,253 | - | 0.6716 - 3.33 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:53:47 | 4 | $ 0.76 | USD |
Gritstone bio (GRTS) Options Flow Summary
Gritstone bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
72.57M | 98.07M | - | 16.34M | -138.49M | -1.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Gritstone bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GRTS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.7271 | 0.8435 | 0.6716 | 0.7523742 | 2,924,693 | 0.0229 | 3.15% |
1 Month | 2.74 | 2.94 | 0.6716 | 1.19 | 5,269,199 | -1.99 | -72.63% |
3 Months | 2.87 | 3.10 | 0.6716 | 1.69 | 2,979,628 | -2.12 | -73.87% |
6 Months | 2.03 | 3.17 | 0.6716 | 1.86 | 2,306,734 | -1.28 | -63.05% |
1 Year | 2.66 | 3.33 | 0.6716 | 1.96 | 1,889,382 | -1.91 | -71.80% |
3 Years | 9.32 | 14.42 | 0.6716 | 4.07 | 1,347,288 | -8.57 | -91.95% |
5 Years | 13.63 | 34.67 | 0.6716 | 6.80 | 1,079,088 | -12.88 | -94.50% |
Gritstone bio Description
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others. |